Clinical Trial Update: Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of dacomitinib in patients with skin squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Squamous Cell Carcinoma

Drugs mentioned

• Dacomitinib (dacomitinib)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Skin Squamous Cell Cancer | Phase 2 | Status: UNKNOWN